Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension (EPICOR)

AstraZeneca

Status: Completed

Conditions: Acute Coronary Syndromes

Study type: Observational

Funder types: Industry

Identifiers

NCT02305680

NIS-CCN-XXX-2014/1 (Other Identifier)

D1843R00049

Details and patient eligibility

About

This study is to describe the long-term antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome in China.

Full description

This study is to describe the long-term (3 to 5 years after the acute coronary syndrome index event) antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome (i.e. ST-segment Elevation Myocardial Infarction, Non-ST-segment Elevation Myocardial Infarction, Unstable Angina) in China.

Enrollment: 2,334 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Written informed consent has been provided.
2. Contact Order Form has been provided
3. Aged 18 years or older.
4. Enrolled in EPICOR Asia study and completed the 2 year follow-up.

Exclusion criteria

1. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances, alcohol or drug abuse).
2. Already included in the EPICOR Asia-China Extension observational study.
3. Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy.
4. Current participation in an interventional clinical trial.
5. Patients receiving ticagrelor beyond 12 months and other off label use.